Industry Analysis

The global  transdermal (percutaneous) drug delivery systems market  held a market value of USD 5,400.2 million in 2017 and is projected to grow at a CAGR of 4.6% over the forecast period. Transdermal drug delivery system (TDDS) delivers drugs into systemic circulation into the skin through the skin at a predetermined rate with minimal inter and intrapatient variation. TDDS has emerged as a potential novel drug delivery system in the past couple of decades to improve the therapeutic efficacy and safety, maintain a steady state plasma level of drugs and overcome disadvantages of the conventional oral dosage forms and parenteral preparations. Some of the major factors driving the market growth are rapid technological advancements in transdermal drug delivery systems and increasing adoption of third-generation delivery systems, the growing geriatric population along with the rise in prevalence of chronic diseases across the world. For instance, as per the data published by the Wo...

The global  near infrared imaging market  held a market value of USD 316 million in 2017 and is projected to grow at a CAGR of 12.6% over the forecast period.  Near infrared imaging uses near infrared light between 650 and 950 nm to non-invasively examine the concentration and oxygenation of hemoglobin which is used to detect changes induced by brain activity, injury, or disease. Moreover, near infrared imaging is portable and inexpensive device which may boost the market during forecast period. Additionally, the growing research and development expenditure by the government as well as private sector is likely to contribute to the market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. Moreover, companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market. Regional...

Doxorubicin is a type of chemotherapy medicine called an anthracycline. It is used to reduce or diminish the growth of cancer cells by blocking an enzyme called topo isomerase. Factors that are propelling the growth of the  doxorubicin market  are surge in geriatric population, rising prevalence of different types of cancer, increasing awareness for cancer treatment. According to the International Federation of Pharmaceutical Manufacturers & Associations, global pharmaceutical industry has spent more than USD 149.8 billion on pharmaceutical Research and development activities. The various side effects, cost containment policies by various governments, stringent regulatory environment for product approval, are likely to hinder market growth during the forecast period. Regional Analysis The American market is expected to dominate the global doxorubicin market during the forecast period due to the presence of major manufacturers, increase in number of cancer cases, awareness ...

The global  positron emission tomography devices (PET) market  is expected to grow at an approximate CAGR of 5.6% during forecast period. Increasing cases of head and neck cancer is the key factor driving the positron emission tomography devices (PET) market. According to the 2018 data suggested by the Australian Institute of Health and Welfare, around 5,091 new cases of head and neck cancer were diagnosed and around 1,034 number of deaths occurred from head and neck cancer in Australia. Various other factors such as increasing cases of cancer, technological advancements, presence of a large target patient population and rising patient awareness regarding the benefits of positron emission tomography scanning are also expected to propel the growth of the market. However, stringent regulatory guidelines, cost associated with  PET scan , and shorter half-life of radioisotopes can hamper the market growth over the forecast period. Segmentation The global positron emission tom...

The Global  interventional neurology market  is expected to grow at an approximate CAGR of 7.8% during forecast period. Increasing participation of market players is the key factor driving the interventional neurology market. For instance, in 2018, Rapid Medical announced CE Mark approval in the European Union for its Tigertriever 13 stent retriever for the treatment of ischemic stroke. Various other factors such as technological advancements, presence of a large target patient population, favorable medical reimbursements and growing demand for effective neurovascular devices are also expected to propel the growth of the market. However, lack of skilled neurosurgeons and stringent regulations can hinder the market growth over the forecast period. Neurointerventional Radiology , or Neuro IR, is a subspecialty of the UCSF Department of Radiology where world-renowned physicians develop and perfect new techniques to treat stroke, brain tumors, cerebral aneurysms and other life thr...

The Global  medication management market  is expected to grow at an approximate CAGR of 13.4% during forecast period. Improvement in medication management workflow of hospitals is the key factor driving the medication management market. For instance, in 2015, Hospital Israelita Albert Einstein (HIAE) enterede an agreement with Swisslog Healthcare Solutions for material transport and medication management to re-engineer its pharmacy processes. Various other factors such as increasing number of healthcare organizations across the globe, advancement in medical technology, and global adoption of IT in the healthcare sector are also boosting the market growth. However, high software implementation and service maintenance costs restraints the market growth during the forecast period. Segmentation The Global medication management market is segmented based on systems, services, mode of delivery, end user and region. The global market for  medication management systems  is se...

The global  animal health market  is expected to grow at a strong 5.7% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The global animal health market was valued at USD 38.5 billion in 2017. Animal health is concerned with treating and preventing animal diseases. Animal health is a valuable part of veterinary science, as conservation of a country’s animal supplies has become increasingly important in recent years. Thus, animal health plays an important role in ensuring the safety of a country’s food supply. The rising incidence of zoonotic diseases is likely to be a major driver for the global animal health market over the forecast period. Zoonotic diseases can affect large animal populations and can wipe out significant chunks in no time. This affects the food supply security of a country. This has led to growing awareness about zoonotic diseases. Zoonotic diseases such as avian flu and swine flu hav...

The Global  Clinical Laboratory Services Market  is Expected to Showcase Exponential Growth Over the Forecast Period, owing to influential factors such as the rising healthcare expenditure globally, and the growing awareness about advanced global clinical laboratory services. The increased occurrence of chronic and infectious diseases such as diabetes, cancer, cardiovascular disorders, liver & kidney disorders, blood disorders, among others, have risen the global demand for improved diagnostics for the early disease detection. According to a report published by Market Research Future (MRFR), the Global Clinical Laboratory Services Market has been assessed to reach a valuation of more than USD 274,400 million at a substantial CAGR by the end of the forecast period. A clinical laboratory, also called medical laboratory, is a healthcare facility in which a wide range of laboratory procedures are carried out on clinical specimens to obtain exact details about the hea...

Global  Bone Growth Stimulator Market  held a market value of USD 1,213 million in 2017 and is projected to grow at a CAGR of 5.86% over the forecast period. Bone Growth Stimulators are devices that are used to boost the healing process during the treatment of the ailments such as spinal fixation, orthopedic fixation, bone fractures and many other. Bone Growth Stimulator enhances the healing process by stimulating the production of new cells, which will allow your fracture to heal considerably faster. This is a perfect approach when you want to get back on your feet quickly. Besides that, one major advantage is surgical operation can be prevented when this approach is used during treatment. Bone growth stimulators have revolutionized the treatment of bone fractures and spinal fusions and are becoming an important tool in the healing process. All these factors contribute to the growth of the bone growth stimulator market. Regional Analysis: Geographically, the Americas is antic...

  Global  Coronary Stents Market  held a market value of USD 9,382.63 million in 2017 and is projected to grow at a CAGR of 7.81% over the forecast period. Coronary stents are used in the process of angioplasty to make the cross-section of the blood vessel wider. Stents hold the walls of the vessel and thus do not let it sag or shrink, thereby curing the blockages in the vessel. Coronary stents have revolutionized the practice of interventional cardiology by reducing early complications such as abrupt vessel closure and improving late clinical outcome (restenosis). This results in patient and physician satisfaction. Thus, this factor contributes heavily to the growth of this market. Regional Analysis: Geographically, the Americas is anticipated to dominate the global coronary stents market owing to the rising prevalence of the cardiovascular diseases such as cardiac arrhythmia, arterial blockage, and  coronary artery stent  disease among others. The development ...

The global  biologics safety testing market  valued of USD 2.79 billion in the year 2017 and is expected to register a CAGR of 13.6% during the forecast period. Biologics safety testing is required for all biopharmaceutical products and vaccines to ensure the product is safe and free of contaminants. Growing pharmaceutical and biotech industry and increasing demand for biological products are expected to drive the growth of the market. However, stringent government regulations for the approval of biosimilars and high cost of drug development are likely to hamper the market growth over the forecast period. Regional Analysis: Geographically, the Americas is expected to dominate the global market owing to the presence of well-established players and rising demand for biological products. Europe is expected to hold the second largest position in the global market owing to the growing pharma and biotech industry. Asia-Pacific is expected to be the fastest growing market owing to th...

As predicted by the report furnished by Market Research Future (MRFR), the global  multiple myeloma treatment market  will be rising steadily at a lucrative CAGR of 11.0% during the forecast period. As per Multiple Myeloma Research Foundation, multiple myeloma generally occurs in bone marrow particularly located in the pelvic bones, spine, ribs, and the area of the hips and shoulders. Apart from this, the groups of myeloma cells prompt other cells present in the bone marrow to get rid of the solid part of the bone, causing osteolytic lesions or soft spots in the bone. This results in weakened bones as well as increasing the risk of fractures. Growing awareness regarding early cancer diagnosis along with the availability of advanced diagnostic techniques like imaging devices and personalized diagnostic tests are expected to provide lucrative growth opportunities for market expansion. The recent launch of monoclonal antibodies (mAbs) Empliciti and daratumumab coupled with effect...